Full federal rescheduling of psilocybin/MDMA does NOT pass Congress this session (by Jan 2027).

Predicted 2026-07-20 · Resolves 2027-01-16 · legislation · USA

71%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

Passing a law through Congress to remove psilocybin or MDMA from the federal banned substances list by January 2027 is extremely unlikely. There simply aren't enough votes, and the political energy around psychedelics is focused on much narrower things — like allowing military veterans to access treatment — rather than broad legalization. Changing a drug's legal status through Congress requires far more political will than currently exists.

Resolution rule: YES if, as of 2027-01-16, no federal statute reclassifying psilocybin or MDMA out of Schedule I has been enacted (signed into law). Check congress.gov for enacted bills. NO if such a law is signed by that date.

Consensus of legislator, dea_officer, veteran_advocate, fda_reviewer. The votes aren't there; access comes via veteran carve-outs and research funding, not sweeping reform.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →